Cargando…

Mid-regional Proadrenomedullin Biomarker Predicts Coronavirus Disease 2019 Clinical Outcomes: A US-Based Cohort Study

BACKGROUND: Mid-regional proadrenomedullin (MR-proADM) is a biomarker released following endothelial damage. Studies have shown a correlation in predicting coronavirus disease 2019 (COVID-19) outcomes with MR-proADM levels. Our study aimed to investigate baseline MR-proADM as a predictor of a wider...

Descripción completa

Detalles Bibliográficos
Autores principales:	Atallah, Natalie J, Panossian, Vahe S, Atallah, Christine J, Schwabe, Andrej, Johannes, Sascha, Wiemer, Jan, Mansour, Michael K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439577/ https://www.ncbi.nlm.nih.gov/pubmed/36072696 http://dx.doi.org/10.1093/ofid/ofac423

Ejemplares similares

856. CT-proET-1 and sFlt-1 as Predictors of Clinical Outcomes in a COVID-19 US Cohort
por: Atallah, Johnny, et al.
Publicado: (2023)

Mid-Regional Proadrenomedullin as a New Biomarker of Kidney and Cardiovascular Diseases—Is It the Future?
por: Czajkowska, Katarzyna, et al.
Publicado: (2021)

Virological and Serological Assessment of US Army Trainees Isolated for Coronavirus Disease 2019
por: Hakre, Shilpa, et al.
Publicado: (2022)

Prognostic value of copeptin and mid‐regional proadrenomedullin in COVID‐19‐hospitalized patients
por: Indirli, Rita, et al.
Publicado: (2022)

Blood Inflammatory Biomarkers Differentiate Inpatient and Outpatient Coronavirus Disease 2019 From Influenza
por: Luciani, Lauren L, et al.
Publicado: (2023)

Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Reported Coronavirus Disease 2019 Cases in US Children, August 2020–May 2021
por: Couture, Alexia, et al.
Publicado: (2022)

Coronavirus Disease 2019–Associated Invasive Fungal Infection
por: Baddley, John W, et al.
Publicado: (2021)

Baseline procalcitonin as a predictor of bacterial infection and clinical outcomes in COVID-19: A case-control study
por: Atallah, Natalie J., et al.
Publicado: (2022)

Superior accuracy of mid-regional proadrenomedullin for mortality prediction in sepsis with varying levels of illness severity
por: Andaluz-Ojeda, David, et al.
Publicado: (2017)

The US Coronavirus Disease 2019 (COVID-19) Surveillance Environment: An Ecological Analysis of the Relationship of Testing Adequacy in the Context of Vaccination
por: Choi, Daesung, et al.
Publicado: (2022)

MR-Proadrenomedullin as biomarker of renal damage in urinary tract infection in children
por: Peñalver Penedo, Rafael, et al.
Publicado: (2021)

Coronavirus Disease 2019-Associated Pulmonary Aspergillosis: Reframing the Debate
por: Clancy, Cornelius J, et al.
Publicado: (2022)

Dying at Home Due to Coronavirus Disease 2019
por: Edwards, Jessie K, et al.
Publicado: (2022)

Contribution of Coronavirus-Specific Immunoglobulin G Responses to Complement Overactivation in Patients with Severe Coronavirus Disease 2019( )
por: Castanha, Priscila M S, et al.
Publicado: (2022)

Procalcitonin, mid-regional proadrenomedullin and C-reactive protein in predicting treatment outcome in community-acquired febrile urinary tract infection
por: Stalenhoef, Janneke Evelyne, et al.
Publicado: (2019)

Coronavirus Disease 2019 Severity and Risk of Subsequent Cardiovascular Events
por: Wiemken, Timothy L, et al.
Publicado: (2022)

Potential Effects of the Coronavirus Disease 2019 (COVID-19) Pandemic on Human Immunodeficiency Virus (HIV) Transmission: A Modeling Study in 32 US Cities
por: Fojo, Anthony, et al.
Publicado: (2022)

Cluster of coronavirus disease 2019 (Covid-19) in the French Alps, 2020
por: Danis, Kostas, et al.
Publicado: (2020)

Endothelial dysfunction and Mid-Regional proAdrenomedullin: What role in SARS-CoV-2 infected Patients?
por: Zaninotto, Martina, et al.
Publicado: (2021)

The kinetic profiles of copeptin and mid regional proadrenomedullin (MR-proADM) in pediatric lower respiratory tract infections
por: Baumann, Philipp, et al.
Publicado: (2022)

Adjunctive Recombinant Human Plasma Gelsolin for Severe Coronavirus Disease 2019 Pneumonia
por: DiNubile, Mark J, et al.
Publicado: (2022)

Community-Acquired Pneumonia in Canada During Coronavirus Disease 2019
por: Mandell, Lionel A, et al.
Publicado: (2022)

Cytokine and Chemokine Levels in Coronavirus Disease 2019 Convalescent Plasma
por: Bonny, Tania S, et al.
Publicado: (2020)

Low Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission by Fomites: A Clinical Observational Study in Highly Infectious Coronavirus Disease 2019 Patients( )
por: Meister, Toni Luise, et al.
Publicado: (2022)

Development of a Standardized Data Collection Tool for Evaluation and Management of Coronavirus Disease 2019
por: Morris, Stephen R, et al.
Publicado: (2020)

Diagnostic and prognostic value of proadrenomedullin in neonatal sepsis
por: Fahmey, Sameh Samir, et al.
Publicado: (2018)

Coronavirus Disease 2019–Associated Pulmonary Aspergillosis: A Noninvasive Screening Model for Additional Diagnostics
por: Permpalung, Nitipong, et al.
Publicado: (2023)

Serologic and Cytokine Signatures in Children With Multisystem Inflammatory Syndrome and Coronavirus Disease 2019
por: Lapp, Stacey A, et al.
Publicado: (2022)

Impact of Vaccination With the SCB-2019 Coronavirus Disease 2019 Vaccine on Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Household Contact Study in the Philippines
por: Tadesse, Birkneh Tilahun, et al.
Publicado: (2022)

High value of mid‐regional proadrenomedullin in COVID‐19: A marker of widespread endothelial damage, disease severity, and mortality
por: Spoto, Silvia, et al.
Publicado: (2021)

The Role of Mid-Regional Proadrenomedullin in the Differential Diagnosis between Culture-Negative and Culture-Positive Sepsis at Emergency Department Admission
por: Mearelli, Filippo, et al.
Publicado: (2022)

Circulating mid-regional proadrenomedullin is a predictor of mortality in patients with COVID-19: a systematic review and meta-analysis
por: Wang, Na, et al.
Publicado: (2023)

Clinical Characteristics of Pregnant Women With Coronavirus Disease 2019 in Wuhan, China
por: Cheng, Biheng, et al.
Publicado: (2020)

Spread of Coronavirus 2019 From Wuhan to Rural Villages in the Hubei Province
por: You, Maolin, et al.
Publicado: (2020)

Clinical Management of Hospitalized Coronavirus Disease 2019 Patients in the United States
por: Mozaffari, Essy, et al.
Publicado: (2021)

AZD7442 (Tixagevimab/Cilgavimab) for Post-Exposure Prophylaxis of Symptomatic Coronavirus Disease 2019
por: Levin, Myron J, et al.
Publicado: (2022)

Protocol-Driven Intensive Outpatient Management of Pregnant Patients With Symptomatic Coronavirus Disease 2019
por: Soffer, M D, et al.
Publicado: (2020)

Characterization of Bacterial and Fungal Infections in Hospitalized Patients With Coronavirus Disease 2019 and Factors Associated With Health Care-Associated Infections
por: Kubin, Christine J, et al.
Publicado: (2021)

Impact of Age and Severe Acute Respiratory Syndrome Coronavirus 2 Breakthrough Infection on Humoral Immune Responses After Three Doses of Coronavirus Disease 2019 mRNA Vaccine
por: Mwimanzi, Francis, et al.
Publicado: (2023)

Pregnancy Status at the Time of Coronavirus Disease 2019 Vaccination and Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
por: Magnus, Maria C, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_03q4rogvg53fh98b9v684tov0b